Skip to content

Dr Leleu

Active
Private limited companyfounded 20241 yr activeKazernenlaan 20, 1040 Etterbeek, BelgiumKBO/BCE: BE 1017.961.649
Summary

The computed 12-month bankruptcy probability of Dr Leleu is 2.5% (moderate). The 2025 annual accounts show equity of €246,118 and a net result of €236,118. The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
Axes
Profitability100
Solvency100
Growth-
Track record67
Bankruptcy probability, 12 months
2.5% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €19,000 at 30 days only on tighter terms
Liquidity ample (current ratio 3.97; short-term debt: 25.1% and cash: 98.5% of total assets), and 25.1% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 1 year 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
74.9%
Return on assets
71.9%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 1 filing
Deviation from the deadline
2025
31 d late
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 26 December 2024, Dr Leleu was incorporated as a Private limited company.1 The company has filed annual accounts once, for fiscal year 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2025

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€246,118
Total assets
€328,531
Net result
€236,118
Working capital
€244,678

Turnover and EBIT margin not published: the micro schema does not require them.

Balance-sheet composition
Assets €328,531
Fixed assets €1,440
Current assets €327,091
Equity and liabilities €328,531
Equity €246,118
Debt €82,412
Debt finances 25.1% of the balance-sheet total.
Key figures and ratios
2025 value
EBITDA
€309,084
Cash flow
€236,426
Current ratio
3.97
Debt to equity
0.33
ROE
95.9%
ROA
71.9%
Interest coverage
1958.09
Debt ≤ 1 year
€82,412
Income taxes
€72,500

Peer companies

Historical observation

Of the 11,280 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 97% are still going.

  • Micro
  • under 2 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.7% went bankrupt
2.6% stopped otherwise
97% still going

For this company itself Checked computes a higher bankruptcy probability: 2.5% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 11,280 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 · 30 lines
Balance sheet Code2025
Assets
Total assets20/58€328,531
Fixed assets21/28€1,440
Tangible fixed assets22/27€1,440
Furniture and vehicles24€1,440
Current assets29/58€327,091
Cash at bank and in hand54/58€323,614
Deferred charges and accrued income490/1€3,477
Equity and liabilities
Total equity and liabilities10/49€328,531
Equity10/15€246,118
Contributions10/11€10,000
Profit (loss) carried forward14€236,118
Amounts payable17/49€82,412
Amounts payable within one year42/48€82,412
Trade debts44€1,533
Suppliers440/4€1,533
Taxes, remuneration and social security45€74,676
Taxes450/3€72,500
Remuneration and social security454/9€2,176
Other amounts payable47/48€6,204
Income statement Code2025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€308
Other operating charges640/8€106
Gross operating margin9900€309,190
Operating profit (loss)9901€308,776
Financial charges65/66B€158
Recurring financial charges65€158
Profit (loss) for the period before taxes9903€308,618
Income taxes67/77€72,500
Profit (loss) for the period9904€236,118
Profit (loss) for the period to be appropriated9905€236,118
Appropriation of the result
Profit (loss) to be appropriated9906€236,118

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€308
Other operating charges640/8€106
Gross operating margin9900€309,190
Operating profit (loss)9901€308,776
Financial charges65/66B€158
Recurring financial charges65€158
Profit (loss) for the period before taxes9903€308,618
Income taxes67/77€72,500
Profit (loss) for the period9904€236,118
Profit (loss) for the period to be appropriated9905€236,118
Line2025
Assets
Total assets20/58€328,531
Fixed assets21/28€1,440
Tangible fixed assets22/27€1,440
Furniture and vehicles24€1,440
Current assets29/58€327,091
Cash at bank and in hand54/58€323,614
Deferred charges and accrued income490/1€3,477
Equity and liabilities
Total equity and liabilities10/49€328,531
Equity10/15€246,118
Contributions10/11€10,000
Profit (loss) carried forward14€236,118
Amounts payable17/49€82,412
Amounts payable within one year42/48€82,412
Trade debts44€1,533
Suppliers440/4€1,533
Taxes, remuneration and social security45€74,676
Taxes450/3€72,500
Remuneration and social security454/9€2,176
Other amounts payable47/48€6,204
Line2025
Profit (loss) for the period9904€236,118
+ Depreciation and write-downs630€308
Operating cash flow (approximation)€236,426

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2026
31-08
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 31 days late
NBB filing
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Etterbeek · 1 establishment unit since 2024
seat establishment The establishment unit on the map
Ground area
222 m²
Building footprint
203 m²
Volume, LiDAR
1,459 m³
Parcel 21363B0377/00N002, Brussels · tallest building 13.2 m, ±3 floors. Linked by address, not a title deed.
10 companies at this address See who is registered here
1 establishment unit
Dr Leleu
Kazernenlaan 20, 1040 EtterbeekGeneral medical practice
since 20242.368.891.735
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21363B0377/00N002 Brussels 222 m² 1 · 203 m² 13.2 m · 3 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Identification & contact

Identification
Legal formPrivate limited company
Founded26-12-2024
Fiscal year end31-12
E-invoicing
Reachable via Peppol
Peppol ID 0208:1017961649
Also 9925:BE1017961649
Registered 21-12-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 30 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.